Abstract
Objective
To evaluate the association between hyperglycemia treatment and mortality in patients with diabetes and COVID-19 in a Peruvian hospital.
Methods
A retrospective cohort study was conducted between March and July 2020. Individual-level data were extracted from an implemented virtual platform. We included patients with type 2 diabetes hospitalized with COVID-19. The assessed outcome was in-hospital mortality. The Independent variable of interest was hyperglycemic treatment. We used Poisson regressions with robust variance to obtain crude and adjusted relative risks (RR) and their 95% confidence intervals (95% CI).
Results
Out of 1635 patients hospitalized for COVID-19 during the study period, 248 patients with diabetes mellitus were included. The majority were men (66.9%), the median age was 62 years. Ninety-seven patients died in the hospital (39.1%). The median glycemia on admission was 222.5 mg/dL. At 48 h after hospital admission, 125 patients (50.4%) received sliding scale insulin alone (SSI), 46 (18.5%) received a fixed-dose insulin regimen. In the adjusted analysis, the group with SSI at 48 h of hospitalization had higher mortality than those with fixed-dose insulin (adjusted RR: 1.69; 95% CI: 1.01 – 2.83), and those and who continued with SSI in the following days had higher mortality compared to the group that switched to fixed-dose insulin (adjusted RR: 1.64; 95% CI: 1.17 – 2.32).
Conclusion
Among assessed patients with diabetes and COVID-19, more than a third died during hospitalization. Early and continuous use of the sliding scale was associated with higher mortality compared to fixed-dose insulin regimens.
【저자키워드】 COVID-19, Mortality, Diabetes Mellitus, Peru, hyperglycemia, Insulin therapy, 【초록키워드】 Treatment, Hospitalized, Hospitalization, hospital, outcome, Patient, Adjusted analysis, age, Hospital admission, insulin, Admission, platform, in-hospital mortality, association, regimen, retrospective cohort study, independent variable, 95% CI, 95% confidence interval, adjusted relative risk, study period, regimens, Poisson regression, glycemia, men, objective, robust, Result, evaluate, died, conducted, median, adjusted, majority, patients died, patients hospitalized, patients with diabete, sliding scale, the median, type 2 diabete, with COVID-19, 【제목키워드】 Treatment, retrospective cohort study, patients with diabete,